MG
IDYA icon

Michael Gelband’s IDEAYA Biosciences IDYA Stock Holding History

Michael Gelband’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,308
Closed -$771K – 1802
2025
Q4 		$771K Sell
22,308
-33,055
-60% -$1.05M 0.01% 1079
2025
Q3 		$1.51M Buy
55,363
+16,643
+43% +$403K 0.02% 823
2025
Q2 		$814K Buy
+38,720
New +$743K 0.01% 1020
2025
Q1 		– Sell
-52,252
Closed -$1.34M – 1712
2024
Q4 		$1.34M Sell
52,252
-343,236
-87% -$9.72M 0.01% 852
2024
Q3 		$12.5M Buy
395,488
+118,690
+43% +$4.5M 0.08% 197
2024
Q2 		$9.72M Buy
+276,798
New +$11M 0.07% 260
2023
Q2 		– Sell
-24,330
Closed -$334K – 2033
2023
Q1 		$334K Buy
24,330
+13,380
+122% +$223K ﹤0.01% 1447
2022
Q4 		$199K Buy
+10,950
New +$184K ﹤0.01% 1461
2022
Q3 		– Sell
-13,099
Closed -$181K – 2078
2022
Q2 		$181K Sell
13,099
-53,196
-80% -$592K ﹤0.01% 1676
2022
Q1 		$742K Buy
+66,295
New +$977K 0.01% 1323
2020
Q3 		– Sell
-23,615
Closed -$336K – 1968
2020
Q2 		$336K Buy
+23,615
New +$186K 0.01% 1260

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Michael Gelband's IDYA Position: Q1 2026 in Review

Michael Gelband sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 22,308 shares — an estimated $771K sold.

Michael Gelband first reported a position in IDYA in Q2 2020 and held it in 11 quarters. The position peaked at $12.5M in Q3 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Michael Gelband reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 22,308 IDEAYA Biosciences shares in Q1 2026, an estimated $771K.
  • Michael Gelband first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 11 quarters.
  • Michael Gelband's IDEAYA Biosciences position peaked at $12.5M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.